Intrauterine Contraceptive Device Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Intrauterine Contraceptive Device Trends and Forecast
The future of the global intrauterine contraceptive device market looks promising with opportunities in the hospital, clinic, and community health care centre markets. The global intrauterine contraceptive device market is expected to reach an estimated $7.4 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of sexually transmitted infections, rising awareness of and acceptance of intrauterine contraceptive devices, and government initiatives to promote family planning.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Intrauterine Contraceptive Device by Segment
The study includes a forecast for the global intrauterine contraceptive device by type, product type, end use, and region.
Intrauterine Contraceptive Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intrauterine contraceptive device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intrauterine contraceptive device companies profiled in this report include-
Lucintel forecasts that hormonal will remain the larger segment over the forecast period due to its increasing adoption for the prevention of unintended pregnancy.
Within this market, hospital will remain the largest segment due to growing number of patient visits for family planning services.
APAC is expected to witness the highest growth over the forecast period due to increased awareness of the advantages of using hormonal devices among in the region.
Features of the Global Intrauterine Contraceptive Device Market
Market Size Estimates: Intrauterine contraceptive device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Intrauterine contraceptive device market size by type, product type, end use, and region in terms of value ($B).
Regional Analysis: Intrauterine contraceptive device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, product types, end uses, and regions for the intrauterine contraceptive device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intrauterine contraceptive device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the intrauterine contraceptive device market size?
Answer: The global intrauterine contraceptive device market is expected to reach an estimated $7.4 billion by 2030.
Q2. What is the growth forecast for intrauterine contraceptive device market?
Answer: The global intrauterine contraceptive device market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the intrauterine contraceptive device market?
Answer: The major drivers for this market are increasing prevalence of sexually transmitted infections, rising awareness of and acceptance of intrauterine contraceptive devices and government initiatives to promote family planning.
Q4. What are the major segments for intrauterine contraceptive device market?
Answer: The future of the intrauterine contraceptive device market looks promising with opportunities in the hospital, clinic, and community health care centre markets.
Q5. Who are the key intrauterine contraceptive device market companies?
Answer: Some of the key intrauterine contraceptive device companies are as follows:
Answer: Lucintel forecasts that hormonal will remain the larger segment over the forecast period due to its increasing adoption for the prevention of unintended pregnancy.
Q7. In intrauterine contraceptive device market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to increased awareness of the advantages of using hormonal devices among in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the intrauterine contraceptive device market by type (hormonal and non-hormonal), product type (mirena, skyla, paragard, essure, levosert, and others), end use (hospitals, clinics, community health care centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Intrauterine Contraceptive Device Market, Intrauterine Contraceptive Device Market Size, Intrauterine Contraceptive Device Market Growth, Intrauterine Contraceptive Device Market Analysis, Intrauterine Contraceptive Device Market Report, Intrauterine Contraceptive Device Market Share, Intrauterine Contraceptive Device Market Trends, Intrauterine Contraceptive Device Market Forecast, Intrauterine Contraceptive Device Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Intrauterine Contraceptive Device Trends and Forecast
The future of the global intrauterine contraceptive device market looks promising with opportunities in the hospital, clinic, and community health care centre markets. The global intrauterine contraceptive device market is expected to reach an estimated $7.4 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of sexually transmitted infections, rising awareness of and acceptance of intrauterine contraceptive devices, and government initiatives to promote family planning.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Intrauterine Contraceptive Device by Segment
The study includes a forecast for the global intrauterine contraceptive device by type, product type, end use, and region.
Intrauterine Contraceptive Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Hormonal
- Non-Hormonal
- Mirena
- Skyla
- Paragard
- Essure
- Levosert
- Others
- Hospitals
- Clinics
- Community Health Care Centres
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intrauterine contraceptive device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intrauterine contraceptive device companies profiled in this report include-
- Eurogine
- Mona Lisa
- Prosan
- Bayer
- Pfizer
- OCON Medical
- Pregna International
Lucintel forecasts that hormonal will remain the larger segment over the forecast period due to its increasing adoption for the prevention of unintended pregnancy.
Within this market, hospital will remain the largest segment due to growing number of patient visits for family planning services.
APAC is expected to witness the highest growth over the forecast period due to increased awareness of the advantages of using hormonal devices among in the region.
Features of the Global Intrauterine Contraceptive Device Market
Market Size Estimates: Intrauterine contraceptive device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Intrauterine contraceptive device market size by type, product type, end use, and region in terms of value ($B).
Regional Analysis: Intrauterine contraceptive device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, product types, end uses, and regions for the intrauterine contraceptive device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intrauterine contraceptive device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the intrauterine contraceptive device market size?
Answer: The global intrauterine contraceptive device market is expected to reach an estimated $7.4 billion by 2030.
Q2. What is the growth forecast for intrauterine contraceptive device market?
Answer: The global intrauterine contraceptive device market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the intrauterine contraceptive device market?
Answer: The major drivers for this market are increasing prevalence of sexually transmitted infections, rising awareness of and acceptance of intrauterine contraceptive devices and government initiatives to promote family planning.
Q4. What are the major segments for intrauterine contraceptive device market?
Answer: The future of the intrauterine contraceptive device market looks promising with opportunities in the hospital, clinic, and community health care centre markets.
Q5. Who are the key intrauterine contraceptive device market companies?
Answer: Some of the key intrauterine contraceptive device companies are as follows:
- Eurogine
- Mona Lisa
- Prosan
- Bayer
- Pfizer
- OCON Medical
- Pregna International
Answer: Lucintel forecasts that hormonal will remain the larger segment over the forecast period due to its increasing adoption for the prevention of unintended pregnancy.
Q7. In intrauterine contraceptive device market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to increased awareness of the advantages of using hormonal devices among in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the intrauterine contraceptive device market by type (hormonal and non-hormonal), product type (mirena, skyla, paragard, essure, levosert, and others), end use (hospitals, clinics, community health care centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Intrauterine Contraceptive Device Market, Intrauterine Contraceptive Device Market Size, Intrauterine Contraceptive Device Market Growth, Intrauterine Contraceptive Device Market Analysis, Intrauterine Contraceptive Device Market Report, Intrauterine Contraceptive Device Market Share, Intrauterine Contraceptive Device Market Trends, Intrauterine Contraceptive Device Market Forecast, Intrauterine Contraceptive Device Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Intrauterine Contraceptive Device Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Intrauterine Contraceptive Device Market by Type
3.3.1: Hormonal
3.3.2: Non-Hormonal
3.4: Global Intrauterine Contraceptive Device Market by Product Type
3.4.1: Mirena
3.4.2: Skyla
3.4.3: Paragard
3.4.4: Essure
3.4.5: Levosert
3.4.6: Others
3.5: Global Intrauterine Contraceptive Device Market by End Use
3.5.1: Hospitals
3.5.2: Clinics
3.5.3: Community Health Care Centres
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Intrauterine Contraceptive Device Market by Region
4.2: North American Intrauterine Contraceptive Device Market
4.2.1: North American Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.2.2: North American Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
4.3: European Intrauterine Contraceptive Device Market
4.3.1: European Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.3.2: European Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
4.4: APAC Intrauterine Contraceptive Device Market
4.4.1: APAC Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.4.2: APAC Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
4.5: ROW Intrauterine Contraceptive Device Market
4.5.1: ROW Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.5.2: ROW Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by Type
6.1.2: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by Product Type
6.1.3: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by End Use
6.1.4: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by Region
6.2: Emerging Trends in the Global Intrauterine Contraceptive Device Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Intrauterine Contraceptive Device Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intrauterine Contraceptive Device Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Eurogine
7.2: Mona Lisa
7.3: Prosan
7.4: Bayer
7.5: Pfizer
7.6: OCON Medical
7.7: Pregna International
2. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Intrauterine Contraceptive Device Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Intrauterine Contraceptive Device Market by Type
3.3.1: Hormonal
3.3.2: Non-Hormonal
3.4: Global Intrauterine Contraceptive Device Market by Product Type
3.4.1: Mirena
3.4.2: Skyla
3.4.3: Paragard
3.4.4: Essure
3.4.5: Levosert
3.4.6: Others
3.5: Global Intrauterine Contraceptive Device Market by End Use
3.5.1: Hospitals
3.5.2: Clinics
3.5.3: Community Health Care Centres
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Intrauterine Contraceptive Device Market by Region
4.2: North American Intrauterine Contraceptive Device Market
4.2.1: North American Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.2.2: North American Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
4.3: European Intrauterine Contraceptive Device Market
4.3.1: European Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.3.2: European Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
4.4: APAC Intrauterine Contraceptive Device Market
4.4.1: APAC Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.4.2: APAC Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
4.5: ROW Intrauterine Contraceptive Device Market
4.5.1: ROW Intrauterine Contraceptive Device Market by Type: Hormonal and Non-Hormonal
4.5.2: ROW Intrauterine Contraceptive Device Market by End Use: Hospitals, Clinics, Community Health Care Centres, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by Type
6.1.2: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by Product Type
6.1.3: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by End Use
6.1.4: Growth Opportunities for the Global Intrauterine Contraceptive Device Market by Region
6.2: Emerging Trends in the Global Intrauterine Contraceptive Device Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Intrauterine Contraceptive Device Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intrauterine Contraceptive Device Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Eurogine
7.2: Mona Lisa
7.3: Prosan
7.4: Bayer
7.5: Pfizer
7.6: OCON Medical
7.7: Pregna International
